| Methods |
Study design: parallel RCT
Study duration: not reported
Study follow‐up: 24 h post‐operatively
|
| Participants |
Country: Canada
Setting: single centre
Inclusion criteria: adults undergoing elective aortocoronary bypass surgery
Number: treatment group (31); control group (26)
Median age ± SD (years): treatment group (62.2 ± 9.5); control group (59.4 ± 9.4)
Sex (M/F): treatment group (25/6); control group (20/6)
Exclusion criteria: previous history of peptic ulcer or GI bleeding; hepatic or kidney insufficiency; insulin dependent DM; known allergy to aspirin or NSAIDs; use of aspirin in the 5 days prior to surgery; gastro‐epiploic artery conduit; weight < 60 kg; inability to operate patient controlled analgesia device
|
| Interventions |
Treatment group
Control group
|
| Outcomes |
|
| Notes |
Funding source: Technilab Inc. supplied study drugs, without any financial support
125 patients were consented and enrolled in the study preoperatively. Fifty‐five patients were excluded post‐operatively due to excessive blood loss. A further 10 patients were excluded due to protocol violations
A very healthy subgroup was studied
|
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Random sequence generation (selection bias) |
Low risk |
Randomisation carried out by pharmacy department |
| Allocation concealment (selection bias) |
Low risk |
Sequential selection of previously randomised envelopes; envelopes containing study drug or placebo |
| Blinding of participants and personnel (performance bias)
All outcomes |
Low risk |
Study drugs and placebo suppositories in envelopes appearing similar |
| Blinding of outcome assessment (detection bias)
All outcomes |
Unclear risk |
Study drugs and placebo suppositories in envelopes appearing similar |
| Incomplete outcome data (attrition bias)
All outcomes |
Low risk |
Reasons for missing outcome data unlikely to be related to true outcome |
| Selective reporting (reporting bias) |
Low risk |
Study protocol matches outcomes presented |
| Other bias |
Low risk |
The study appears to be free of other sources of bias |